We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Disclaimer
This presentation paper is provided on the TGA's website solely for the purpose of indicating or suggesting what TGA representatives spoke about to the various conferences and seminars to which it relates. The paper is not legislative in nature and should not be taken to be statements of any law or policy in any way.
The Australian Government Department of Health (of which the TGA is a part) advises that (a) the presentation paper should not be relied upon in any way as representing a comprehensive description of regulatory requirements, and (b) cannot guarantee, and assumes no legal liability or responsibility for, the accuracy, currency or completeness of the information contained in the presentation paper.
Presentation
- Presented by:
- Gillian Mitchell (TGA)
- Patrick O’Meley (TGA)
- Shari Krasowski (TGA)
- Dom Watsons (Folk)
- Jim McCool (Folk)
- Nick Zappia (Deloitte)
- Presented at: Online webinar
- Presentation date: 29 July 2021
- Presentation summary: The Therapeutic Goods Administration (TGA) is embarking on a transformation program to change and improve the way we deliver services to our stakeholders.
We aim to transform the way the TGA serves its stakeholders in three key areas: Efficient processes, Connected data, Digital practices.
The TGA Transformation Stakeholder Engagement Forums specifically asked for feedback on three areas:- User experiences of using the TGA website, including what information or tools you are typically seeking, and how easy it is to find, understand and act on
- User experiences of searching the ARTG and the barriers and obstacles to achieving their objectives
- User experiences of interacting with the TGA, including current pain points and opportunities for improvement
